Having excluded an obligatory role for IGFBP-1 in maintaining normal metabolism, we next investigated whether loss of circulating IGFBP-1 predisposes to obesity-induced glucose intolerance and insulin resistance, as suggested by human observational data [9–11]. Here, IGFBP1 is linked to obesity disorder.